Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Corporate Management Tips From Three Former/Outgoing Device CEOs

This article was originally published in The Gray Sheet

Executive Summary

John Brown of Stryker, Jack Wareham of Beckman Coulter and Ron Dollens of Guidant, who have a cumulative 50 years of experience spearheading large corporations, each began in pharma. After working at Squibb Corp., Brown served as CEO of Stryker for 28 years, retiring in January; he remains as chairman. Wareham worked at SmithKline before joining Beckman Instruments in 1984 and becoming president in 1993 and CEO in 1998. He retired as CEO in January and will step down as chairman in April. Dollens came up through Eli Lilly and has served as CEO of Guidant since 1995. He plans to retire once Guidant merges with Johnson & Johnson. Their comments derive from a March 4 Q&A session at AdvaMed's annual meeting in Dana Point, Calif.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT021764

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel